Method Validation Is Claim-Specific

Overview

Short answer: No — you cannot assume a method validated for one analyte, concentration range, or matrix is valid for another without fresh evidence tied to the new claim. Validation establishes fitness for a specific measurement claim (analyte, matrix, concentration range, sample preparation, and intended use). To decide whether an existing validation applies, examine how the original validation addressed identity, selectivity, calibration, accuracy, precision, range, sensitivity, robustness, and matrix effects — and identify gaps that require new data or justification .

Why this matters: a method’s published validation demonstrates that, under specified conditions, it performs acceptably for a stated claim. Change any element of that claim and the evidentiary basis may no longer hold. The rest of this article gives a practical structure for reading validation evidence so you can judge whether a method’s validation maps to your intended measurement.

Identity — does the method detect the correct target?

Selectivity (specificity) — can the method distinguish analyte from other components?

Calibration and linearity — does the calibration model hold for your range?

Accuracy (trueness) — what evidence shows the method measures the true value?

Precision — are repeatability and reproducibility acceptable for your use?

Range and sensitivity — are limits suitable for decision-making?

Robustness — how sensitive is the method to deliberate changes?

Matrix effects — the single biggest source of transfer failure

Putting the pieces together: evidence-reading checklist

What remains unresolved without new primary evidence

Recommended practical next steps (non-prescriptive)

A clear, evidence-focused read of validation reports prevents unwarranted extrapolation. Validation shows what was demonstrated; it does not prove what was not tested. Use the nine-domain frame to decide where additional data are needed to support any new claim .

• What was the analyte definition in the validation? Was identity based on retention time, spectral match, mass fragmentation, or a combination? Methods that rely only on retention time or a single detector response are more vulnerable to coelution or interferences if the matrix or sample composition changes .
• Ask whether the validation included orthogonal identity tests (e.g., retention time plus mass spectral confirmation). If not, a different analyte or a structurally related compound in your matrix could produce the same signal; new identity work may be needed.
• Review the experiments used to demonstrate selectivity: was the method challenged with likely interferents, degradation products, excipients, or endogenous matrix components? If those challenges were narrow or limited to a different matrix, selectivity in your matrix is unproven .
• A change in sample type (e.g., switching from water to serum, or from plant extract to baked food) typically introduces new potential interferents; you need either evidence that the method separates those components or targeted tests showing no interference.
• Check the validated calibration range (concentration limits and number/type of calibration points) and model (linear, weighted). If your target concentrations fall outside the validated range, the calibration model’s uncertainty and bias are unknown there.
• Even within the same nominal range, a different matrix can change response factors (ion suppression/enhancement in mass spectrometry, detector quenching), so re-evaluation of calibration slope and intercept may be required .
• Accuracy in a validation is usually demonstrated by recovery experiments (spike/recovery) or comparison with a reference method. Confirm whether recovery levels and spike matrices match your intended samples.
• If the original study used matrix-matched spikes or certified reference materials (CRMs), accuracy claims are stronger for that matrix. If not, you cannot infer trueness for a different matrix without comparable recovery or reference comparisons.
• Precision should be reported as within-run (repeatability) and between-run or between-operator (intermediate precision). Examine actual reported variability at concentrations relevant to your claim.
• Changing analyte concentration, operators, instrumentation, or sample preparation can all increase observed variability; if your context differs from the validation, expect to obtain fresh precision data.
• The validated range establishes where accuracy and precision were demonstrated. Sensitivity measures (LOD/LOQ) indicate the lowest reliably reportable concentrations.
• If your decision thresholds are near the LOQ from the validation, any matrix or analyte change can push the effective LOQ higher; you need evidence showing the method reaches the same sensitivity in the new context .
• Robustness assessments intentionally vary method parameters (temperature, pH, column, reagent lots) to see if performance remains acceptable. Robustness data help justify minor transfer or equipment differences.
• Lack of robustness data means even small changes (different instrument model, column brand, or technician) could materially affect results; you should either generate robustness data or avoid extrapolating the original claim.
• Matrix effects (ion suppression/enhancement, chemical interferences, adsorption) often differ by sample type. A method validated in one matrix is not automatically valid in another unless matrix equivalence is demonstrated.
• Practical evidence to seek: matrix-matched calibration or standard addition studies, recovery across representative matrix lots, and tests of matrix effect magnitude. If those are absent, plan directed experiments in your matrix rather than relying on the original validation .
• Confirm the original claim: analyte(s), matrix, extraction/preparation, calibration model, concentration range, instrument, and intended purpose.
• For each of the nine domains above (identity, selectivity, calibration, accuracy, precision, range, sensitivity, robustness, matrix), identify whether the validation presented direct, matrix-matched data that cover your intended use or indirect evidence plus scientific rationale. Prefer direct, quantitative evidence.
• If evidence is missing or limited, ask whether the gap can be bridged with targeted experiments (e.g., spike/recovery in your matrix, selectivity tests with likely interferents, calibration verification) or whether a full re-validation for the new claim is required.
• Whether the method will meet specific performance requirements in a different matrix or at a different concentration range cannot be assumed from a separate validation; it remains an empirical question until demonstrated.
• Claims about accreditation, official acceptance, health conclusions, or fitness for regulatory submission require current primary documentation specific to the claim and are not established solely by another laboratory’s validation report.
• Map your intended measurement claim precisely.
• Compare that claim to the published validation details using the checklist above.
• Where direct, matrix-matched evidence is absent, plan focused experiments targeted to the missing domains rather than assuming transferability.